RICHARD F POPS
CIK 1126490 · Director and CEO, Alkermes plc · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$67.04M
Companies
5
Total Filings
215
Lifetime Open-Market Net
-$140.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Director | 37,798 | $159.76 | $6.04M | -$13.18M | 39 | 2026-05-29 |
| ALKS | Director and CEO, Alkermes plc | 1,377,740 | $44.28 | $61.01M | -$125.56M | 158 | 2026-03-04 |
| Epizyme, Inc. (EPZM) Delisted | Director | — | $1.47 | — | $0 | 8 | 2020-06-02 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 32,500 | $178.75 | $5.81M | -$1.55M | 8 | 2019-01-29 |
| EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | Director | — | — | — | $0 | 2 | 2008-06-02 |
Recent Filings · Page 6 of 22
215 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-14 | ALKS | Mixed | — | -$1.49M | EDGAR |
| 2019-03-07 | ALKS | Mixed | — | -$1.25M | EDGAR |
| 2019-03-04 | ALKS | Mixed | +9,730 | -$267.6K | EDGAR |
| 2019-02-27 | ALKS | Mixed | +6,113 | -$131.8K | EDGAR |
| 2019-02-25 | ALKS | Grant (A) | — | $0 | EDGAR |
| 2019-02-19 | ALKS | Mixed | +18,962 | -$257.5K | EDGAR |
| 2019-01-29 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +1,250 | $0 | EDGAR |
| 2018-12-11 | ALKS | Mixed | +15,276 | -$415.7K | EDGAR |
| 2018-11-27 | NBIX | Sell (S) | −4,124 | -$376.8K | EDGAR |
| 2018-11-13 | NBIX | Sell (S) | −4,123 | -$425.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.